Skip to main content
Erschienen in: Cancer Causes & Control 1/2006

01.02.2006 | Original Paper

Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis

verfasst von: Margaret R. Karagas, Michael S. Zens, Therese A. Stukel, Anthony J. Swerdlow, Stefano Rosso, Anne Osterlind, Thomas Mack, Connie Kirkpatrick, Elizabeth A. Holly, Adele Green, Richard Gallagher, J. Mark Elwood, Bruce K. Armstrong

Erschienen in: Cancer Causes & Control | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

There is evidence that pregnancy history including age at first birth and parity may play a role in risk of cutaneous melanoma in women, although, epidemiological findings are inconsistent. We conducted a collaborative analysis of these factors using the original data from ten completed case–control studies (2391 cases and 3199 controls), and assessed the potential confounding effects of socioeconomic, pigmentary, and sun exposure-related factors. We found no overall association with ever having a live birth (pooled odds ratio (pOR) 0.95, 95% confidence interval (CI) 0.67–1.35). However, we detected a reduced risk of melanoma among women with higher parity (≥5 versus no live births pOR 0.76, 95% CI 0.49–1.18, each live birth pOR 0.95, 95% CI 0.91–0.99, p trend = 0.05). Women with both earlier age at first birth (e.g., <20 years) and higher parity (e.g., ≥5 live births) had a particularly lower risk than women with later age at first birth (e.g., ≥25 years) and lower parity (e.g., <5 live births) (pOR 0.33, 95% CI 0.14–0.75). The results are compatible with an effect of reproductive history-related factors on melanoma risk, but also could reflect differences in other factors, such as sun exposure history.
Literatur
1.
Zurück zum Zitat Lambe, M, Thorn, M, Sparen, P, Bergstrom, R, Adami, HO 1996Malignant melanoma: reduced risk associated with early childbearing and multiparityMelanoma Res6147153PubMed Lambe, M, Thorn, M, Sparen, P, Bergstrom, R, Adami, HO 1996Malignant melanoma: reduced risk associated with early childbearing and multiparityMelanoma Res6147153PubMed
2.
Zurück zum Zitat Stukel, TA, Demidenko, E, Dykes, J, Karagas, MR 2001Two-stage methods for the analysis of pooled dataStat Med2021152130PubMedCrossRef Stukel, TA, Demidenko, E, Dykes, J, Karagas, MR 2001Two-stage methods for the analysis of pooled dataStat Med2021152130PubMedCrossRef
3.
Zurück zum Zitat Karagas, MR, Stukel, TA, Dykes, J, et al. 2002A pooled analysis of 10 case–control studies of melanoma and oral contraceptive useBr J Cancer8610851092PubMedCrossRef Karagas, MR, Stukel, TA, Dykes, J,  et al. 2002A pooled analysis of 10 case–control studies of melanoma and oral contraceptive useBr J Cancer8610851092PubMedCrossRef
4.
Zurück zum Zitat Beral, V, Ramcharan, S, Faris, R 1977Malignant melanoma and oral contraceptive use among women in CaliforniaBr J Cancer36804809PubMed Beral, V, Ramcharan, S, Faris, R 1977Malignant melanoma and oral contraceptive use among women in CaliforniaBr J Cancer36804809PubMed
5.
Zurück zum Zitat Elwood, JM, Whitehead, SM, Davison, J, Stewart, M, Galt, M 1990Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburnInt J Epidemiol19801810PubMed Elwood, JM, Whitehead, SM, Davison, J, Stewart, M, Galt, M 1990Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburnInt J Epidemiol19801810PubMed
6.
Zurück zum Zitat Gallagher, RP, Elwood, JM, Hill, GB, Coldman, AJ, Threlfall, WJ, Spinelli, JJ 1985Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma StudyBr J Cancer52901907PubMed Gallagher, RP, Elwood, JM, Hill, GB, Coldman, AJ, Threlfall, WJ, Spinelli, JJ 1985Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma StudyBr J Cancer52901907PubMed
7.
Zurück zum Zitat Green, A, Bain, C 1985Hormonal factors and melanoma in womenMed J Aust142446448PubMed Green, A, Bain, C 1985Hormonal factors and melanoma in womenMed J Aust142446448PubMed
8.
Zurück zum Zitat Zanetti, R, Franceschi, S, Rosso, S, Bidoli, E, Colonna, S 1990Cutaneous malignant melanoma in females: the role of hormonal and reproductive factorsInt J Epidemiol19522526PubMed Zanetti, R, Franceschi, S, Rosso, S, Bidoli, E, Colonna, S 1990Cutaneous malignant melanoma in females: the role of hormonal and reproductive factorsInt J Epidemiol19522526PubMed
9.
Zurück zum Zitat Holman, CD, Armstrong, BK, Heenan, PJ 1984Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factorsBr J Cancer50673680PubMed Holman, CD, Armstrong, BK, Heenan, PJ 1984Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factorsBr J Cancer50673680PubMed
10.
Zurück zum Zitat Kirkpatrick, CS, White, E, Lee, JA 1994Case–control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesityAm J Epidemiol139869880PubMed Kirkpatrick, CS, White, E, Lee, JA 1994Case–control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesityAm J Epidemiol139869880PubMed
11.
Zurück zum Zitat Holly, EA, Weiss, NS, Liff, JM 1983Cutaneous melanoma in relation to exogenous hormones and reproductive factorsJ Natl Cancer Inst70827831PubMed Holly, EA, Weiss, NS, Liff, JM 1983Cutaneous melanoma in relation to exogenous hormones and reproductive factorsJ Natl Cancer Inst70827831PubMed
12.
Zurück zum Zitat Holly, EA, Cress, RD, Ahn, DK 1995Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive useAm J Epidemiol141943950PubMed Holly, EA, Cress, RD, Ahn, DK 1995Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive useAm J Epidemiol141943950PubMed
13.
Zurück zum Zitat Langholz, B, Richardson, J, Rappaport, E, Waisman, J, Cockburn, M, Mack, T 2000Skin characteristics and risk of superficial spreading and nodular melanoma (United States)Cancer Causes Control11741750PubMedCrossRef Langholz, B, Richardson, J, Rappaport, E, Waisman, J, Cockburn, M, Mack, T 2000Skin characteristics and risk of superficial spreading and nodular melanoma (United States)Cancer Causes Control11741750PubMedCrossRef
14.
Zurück zum Zitat Osterlind, A, Tucker, MA, Stone, BJ, Jensen, OM 1988The Danish case–control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in womenInt J Cancer42821824PubMed Osterlind, A, Tucker, MA, Stone, BJ, Jensen, OM 1988The Danish case–control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in womenInt J Cancer42821824PubMed
15.
Zurück zum Zitat Swerdlow, AJ, English, J, MacKie, RM, et al. 1986Benign melanocytic naevi as a risk factor for malignant melanomaBr Med J (Clin Res Ed)29215551559CrossRef Swerdlow, AJ, English, J, MacKie, RM,  et al. 1986Benign melanocytic naevi as a risk factor for malignant melanomaBr Med J (Clin Res Ed)29215551559CrossRef
16.
Zurück zum Zitat DerSimonian, R, Laird, N 1986Meta-analysis in clinical trialsControl Clin Trials7177188PubMed DerSimonian, R, Laird, N 1986Meta-analysis in clinical trialsControl Clin Trials7177188PubMed
17.
Zurück zum Zitat Bliss, JM, Ford, D, Swerdlow, AJ, et al. 1995Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case–control studiesInt J Cancer62367376The International Melanoma Analysis Group (IMAGE)PubMed Bliss, JM, Ford, D, Swerdlow, AJ,  et al. 1995Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case–control studiesInt J Cancer62367376The International Melanoma Analysis Group (IMAGE)PubMed
18.
Zurück zum Zitat Ford, D, Bliss, JM, Swerdlow, AJ, et al. 1995Risk of cutaneous melanoma associated with a family history of the diseaseInt J Cancer62377381The International Melanoma Analysis Group (IMAGE)PubMed Ford, D, Bliss, JM, Swerdlow, AJ,  et al. 1995Risk of cutaneous melanoma associated with a family history of the diseaseInt J Cancer62377381The International Melanoma Analysis Group (IMAGE)PubMed
19.
Zurück zum Zitat Wyshak, G, Frisch, RE, Albright, NL, Albright, TE, Schiff, I 1989Reproductive factors and melanoma of the skin among womenInt J Dermatol28527530PubMed Wyshak, G, Frisch, RE, Albright, NL, Albright, TE, Schiff, I 1989Reproductive factors and melanoma of the skin among womenInt J Dermatol28527530PubMed
20.
Zurück zum Zitat Hannaford, PC, Villard-Mackintosh, L, Vessey, MP, Kay, CR 1991Oral contraceptives and malignant melanomaBr J Cancer63430433PubMed Hannaford, PC, Villard-Mackintosh, L, Vessey, MP, Kay, CR 1991Oral contraceptives and malignant melanomaBr J Cancer63430433PubMed
21.
Zurück zum Zitat Bain, C, Hennekens, CH, Speizer, FE, Rosner, B, Willett, W, Belanger, C 1982Oral contraceptive use and malignant melanomaJ Natl Cancer Inst68537539PubMed Bain, C, Hennekens, CH, Speizer, FE, Rosner, B, Willett, W, Belanger, C 1982Oral contraceptive use and malignant melanomaJ Natl Cancer Inst68537539PubMed
22.
Zurück zum Zitat Westerdahl, J, Olsson, H, Masback, A, Ingvar, C, Jonsson, N 1996Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factorsBr J Cancer7311261131PubMed Westerdahl, J, Olsson, H, Masback, A, Ingvar, C, Jonsson, N 1996Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factorsBr J Cancer7311261131PubMed
23.
Zurück zum Zitat Smith, MA, Fine, JA, Barnhill, RL, Berwick, M 1998Hormonal and reproductive influences and risk of melanoma in womenInt J Epidemiol27751757PubMedCrossRef Smith, MA, Fine, JA, Barnhill, RL, Berwick, M 1998Hormonal and reproductive influences and risk of melanoma in womenInt J Epidemiol27751757PubMedCrossRef
24.
Zurück zum Zitat Ron, E, Lunenfeld, B, Menczer, J, et al. 1987Cancer incidence in a cohort of infertile womenAm J Epidemiol125780790PubMed Ron, E, Lunenfeld, B, Menczer, J,  et al. 1987Cancer incidence in a cohort of infertile womenAm J Epidemiol125780790PubMed
25.
Zurück zum Zitat Rossing, MA, Daling, JR, Weiss, NS, Moore, DE, Self, SG 1995Risk of cutaneous melanoma in a cohort of infertile womenMelanoma Res5123127PubMed Rossing, MA, Daling, JR, Weiss, NS, Moore, DE, Self, SG 1995Risk of cutaneous melanoma in a cohort of infertile womenMelanoma Res5123127PubMed
26.
Zurück zum Zitat Brinton, LA, Melton, LJ,3rd, Malkasian, GD,Jr., Bond, A, Hoover, R 1989Cancer risk after evaluation for infertilityAm J Epidemiol129712722PubMed Brinton, LA, Melton, LJ,3rd, Malkasian, GD,Jr., Bond, A, Hoover, R 1989Cancer risk after evaluation for infertilityAm J Epidemiol129712722PubMed
27.
Zurück zum Zitat Young, P, Purdie, D, Jackman, L, Molloy, D, Green, A 2001A study of infertility treatment and melanomaMelanoma Res11535541PubMedCrossRef Young, P, Purdie, D, Jackman, L, Molloy, D, Green, A 2001A study of infertility treatment and melanomaMelanoma Res11535541PubMedCrossRef
28.
Zurück zum Zitat Sanchez, NP, Pathak, MA, Sato, S, Fitzpatrick, TB, Sanchez, JL, Mihm, MC,Jr. 1981Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence studyJ Am Acad Dermatol4698710PubMedCrossRef Sanchez, NP, Pathak, MA, Sato, S, Fitzpatrick, TB, Sanchez, JL, Mihm, MC,Jr. 1981Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence studyJ Am Acad Dermatol4698710PubMedCrossRef
29.
Zurück zum Zitat Cummings, K, Derbes, V 1967Dermatoses associated with pregnancyCutis3120125 Cummings, K, Derbes, V 1967Dermatoses associated with pregnancyCutis3120125
30.
Zurück zum Zitat Foucar, E, Bentley, TJ, Laube, DW, Rosai, J 1985A histopathologic evaluation of nevocellular nevi in pregnancyArch Dermatol121350354PubMedCrossRef Foucar, E, Bentley, TJ, Laube, DW, Rosai, J 1985A histopathologic evaluation of nevocellular nevi in pregnancyArch Dermatol121350354PubMedCrossRef
31.
Zurück zum Zitat Snell, RS, Bischitz, PG 1960The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentationJ Invest Dermatol357382PubMedCrossRef Snell, RS, Bischitz, PG 1960The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentationJ Invest Dermatol357382PubMedCrossRef
32.
Zurück zum Zitat Lopez, RE, Bhakoo, H, Paolini, NS, Rosen, F, Holyoke, ED, Goldrosen, MH 1978Effect of estrogen on the growth of B-16 melanomaSurg Forum29153154PubMed Lopez, RE, Bhakoo, H, Paolini, NS, Rosen, F, Holyoke, ED, Goldrosen, MH 1978Effect of estrogen on the growth of B-16 melanomaSurg Forum29153154PubMed
33.
Zurück zum Zitat Beattie, CW, Ronan, SG, Amoss, MS,Jr. 1991Estrogens influence the natural history of Sinclair swine cutaneous melanomaCancer Research5120252028PubMed Beattie, CW, Ronan, SG, Amoss, MS,Jr. 1991Estrogens influence the natural history of Sinclair swine cutaneous melanomaCancer Research5120252028PubMed
34.
Zurück zum Zitat Armstrong, B, English, DR 1996Cutaneous malignant melanoma.Schottenfeld, DFraumeni, J eds. Cancer Epidemiology and PreventionOxford University PressNew York12821312 Armstrong, B, English, DR 1996Cutaneous malignant melanoma.Schottenfeld, DFraumeni, J eds. Cancer Epidemiology and PreventionOxford University PressNew York12821312
35.
Zurück zum Zitat Boland, SL, Shaw, HM, Milton, GW 1976Multiple primary cancers in patients with malignant melanomaMed J Aust1517519PubMed Boland, SL, Shaw, HM, Milton, GW 1976Multiple primary cancers in patients with malignant melanomaMed J Aust1517519PubMed
36.
Zurück zum Zitat Tucker, MA, Boice, JD, Hoffman, DA 1985Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82Natl Cancer Inst Monogr68161189PubMed Tucker, MA, Boice, JD, Hoffman, DA 1985Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82Natl Cancer Inst Monogr68161189PubMed
37.
Zurück zum Zitat Koh, HK, Sober, AJ, Carey, RA 1987Possible association between malignant melanoma and breast cancerArch Dermatol123712713PubMed Koh, HK, Sober, AJ, Carey, RA 1987Possible association between malignant melanoma and breast cancerArch Dermatol123712713PubMed
38.
Zurück zum Zitat Gutman, M, Cnaan, A, Inbar, M, et al. 1991Are malignant melanoma patients at higher risk for a second cancer?Cancer68660665PubMed Gutman, M, Cnaan, A, Inbar, M,  et al. 1991Are malignant melanoma patients at higher risk for a second cancer?Cancer68660665PubMed
39.
Zurück zum Zitat Harvey, EB, Brinton, LA 1985Second cancer following cancer of the breast in Connecticut, 1935–82Natl Cancer Inst Monogr6899112PubMed Harvey, EB, Brinton, LA 1985Second cancer following cancer of the breast in Connecticut, 1935–82Natl Cancer Inst Monogr6899112PubMed
40.
Zurück zum Zitat Volk, N, Pompe-Kirn, V 1997Second primary cancers in breast cancer patients in SloveniaCancer Causes Control8764770PubMedCrossRef Volk, N, Pompe-Kirn, V 1997Second primary cancers in breast cancer patients in SloveniaCancer Causes Control8764770PubMedCrossRef
41.
Zurück zum Zitat Beral, V, Evans, S, Shaw, H, Milton, G 1984Oral contraceptive use and malignant melanoma in AustraliaBr J Cancer50681685PubMed Beral, V, Evans, S, Shaw, H, Milton, G 1984Oral contraceptive use and malignant melanoma in AustraliaBr J Cancer50681685PubMed
42.
Zurück zum Zitat Green, A, Trichopoulos, D 2002Skin CancerAdami, HOHunter, DTrichopoulos, D eds. Textbook of Cancer EpidemiologyOxford University PressNew York281300 Green, A, Trichopoulos, D 2002Skin CancerAdami, HOHunter, DTrichopoulos, D eds. Textbook of Cancer EpidemiologyOxford University PressNew York281300
Metadaten
Titel
Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis
verfasst von
Margaret R. Karagas
Michael S. Zens
Therese A. Stukel
Anthony J. Swerdlow
Stefano Rosso
Anne Osterlind
Thomas Mack
Connie Kirkpatrick
Elizabeth A. Holly
Adele Green
Richard Gallagher
J. Mark Elwood
Bruce K. Armstrong
Publikationsdatum
01.02.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 1/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0281-y

Weitere Artikel der Ausgabe 1/2006

Cancer Causes & Control 1/2006 Zur Ausgabe

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.